首页 > 市场调查报告书 > 医疗设备

体外诊断感染疾病

市场调查报告书

商品编码

1746892

日本流感诊断市场报告（按产品、检测类型、流感类型、最终用户和地区）2025 年至 2033 年

Japan Influenza Diagnostics Market Report by Product, Test Type, Type of Flu, End User, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 115 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2024年，日本流感诊断市场规模达6,320万美元。展望未来， IMARC Group预计到2033年，该市场规模将达到1.05亿美元，2025-2033年期间的复合年增长率（CAGR）为5.3%。推动该市场发展的因素包括疫苗接种活动的扩大、即时检测的便利性、流感病毒研究的深入以及公共卫生倡议带来的认知提升。

流感，通常简称为流感，是一种主要攻击呼吸系统的病毒性感染，会影响鼻腔、喉咙和肺部等部位。流感诊断涵盖多种免疫测定检测，旨在检测呼吸道检体中甲型和乙型流感病毒的核蛋白抗原。可用的诊断方法包括快速抗原检测、逆转录聚合酶炼式反应 (RT-PCR)、免疫萤光检测、血清学检测和快速分子检测。医疗专业人员依靠这些诊断方法快速识别和分类流感病毒株，从而促进有效的治疗决策并实现高效的公共卫生管理。

日本流感诊断市场趋势：

日本流感诊断市场正经历大幅成长，这得益于多种因素的共同推动。其中最主要的是流感疫情的不断增加，这使得有效的诊断解决方案变得至关重要。此外，人们对全球大流行可能性的日益担忧，也刺激了对诊断能力的投资，为市场扩张做出了重大贡献。此外，该领域的持续技术进步正在提高诊断测试的准确性和速度，从而对市场的成长轨迹产生了积极的影响。此外，以及时检测的重要性为重点的公众意识宣传活动，鼓励了更多人寻求诊断服务，进一步刺激了市场需求。日本不断增长的医疗保健支出支持了先进诊断方法的采用，从而促进了市场成长。此外，更容易患重症流感的长者也推动了对诊断服务的需求成长。日本城市人口的成长导致感染率上升，凸显了对强大诊断解决方案的需求。频繁的国内和国际旅行加速了流感的传播，进一步凸显了高效诊断的重要性。这些因素将在预测期内共同为日本流感诊断市场创造大量机会。

日本流感诊断市场细分：

产品洞察：

检测试剂盒和试剂
仪器
其他的

测试类型洞察：

分子诊断测试
- 聚合酶炼式反应
- 等温核酸扩增试验
- 其他的
传统诊断测试
- 快速流感诊断测试
- 病毒培养测试
- 直接萤光抗体检测
- 血清学检测

流感洞察类型：

A型流感
B型流感
C型流感

最终用户洞察：

医院
诊断实验室
其他的

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪錶板和公司评估象限等竞争分析。此外，报告还提供了所有主要公司的详细资料。

本报告回答的关键问题：

日本流感诊断市场迄今表现如何？未来几年将如何表现？
COVID-19 对日本流感诊断市场有何影响？
日本流感诊断市场依产品划分是怎样的？
根据检测类型，日本流感诊断市场是如何分類的？
日本流感诊断市场根据流感类型如何划分？
根据最终用户，日本流感诊断市场是如何分布的？
日本流感诊断市场的价值链分为哪些阶段？
日本流感诊断的主要驱动因素和挑战是什么？
日本流感诊断市场的结构是怎么样的？主要参与者是谁？
日本流感诊断市场的竞争程度如何？

本报告回答的关键问题：

日本流感诊断市场迄今表现如何？未来几年将如何表现？
COVID-19 对日本流感诊断市场有何影响？
日本流感诊断市场依产品划分是怎样的？
根据检测类型，日本流感诊断市场是如何分類的？
日本流感诊断市场根据流感类型如何划分？
根据最终用户，日本流感诊断市场是如何分布的？
日本流感诊断市场的价值链分为哪些阶段？
日本流感诊断的主要驱动因素和挑战是什么？
日本流感诊断市场的结构是怎么样的？主要参与者是谁？
日本流感诊断市场的竞争程度如何？

Japan influenza diagnostics market size reached USD 63.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 105.0 Million by 2033, exhibiting a growth rate (CAGR) of 5.3% during 2025-2033. The market is being driven by several factors, including the expansion of vaccination campaigns, the convenience offered by point-of-care testing, intensified research into influenza viruses, and increased awareness through public health initiatives.

Influenza, commonly referred to as the flu, is a viral infection that primarily targets the respiratory system, affecting areas such as the nose, throat, and lungs. The realm of influenza diagnostics encompasses a variety of immunoassay tests designed to detect the presence of nucleoprotein antigens from influenza A and B viruses in respiratory samples. Among the available diagnostic methods are rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, serological tests, and rapid molecular assays. These diagnostic options are relied upon by healthcare professionals to promptly identify and categorize influenza strains, facilitating effective treatment decisions and enabling efficient public health management.

Japan Influenza Diagnostics Market Trends:

The influenza diagnostics market in Japan is witnessing substantial growth, driven by a combination of factors. Foremost among these is the increasing incidence of flu outbreaks, which necessitates effective diagnostic solutions. Apart from this, the growing concerns regarding the potential for pandemics have spurred investments in diagnostic capabilities, making a significant contribution to market expansion. Furthermore, continuous technological advancements in the field are enhancing the accuracy and speed of diagnostic tests, positively impacting the market's growth trajectory. Besides this, public awareness campaigns focused on the importance of timely testing have encouraged more individuals to seek diagnostic services, further catalyzing market demand. Japan's rising healthcare spending supports the adoption of advanced diagnostic methods, contributing to market growth. Additionally, elderly individuals, who are more vulnerable to severe cases of the flu, are driving increased demand for diagnostic services. The growth of urban populations in Japan has led to higher infection rates, underscoring the need for robust diagnostic solutions. Frequent travel within the country and internationally has accelerated the spread of the flu, further highlighting the importance of efficient diagnostics. These factors will collectively create numerous opportunities for the influenza diagnostics market in Japan over the forecasted period.

Japan Influenza Diagnostics Market Segmentation:

Product Insights:

Test Kit and Reagents
Instruments
Others

Test Type Insights:

Molecular Diagnostic Tests
- Polymerase Chain Reaction
- Isothermal Nucleic Acid Amplification Tests
- Others
Traditional Diagnostic Tests
- Rapid Influenza Diagnostic Tests
- Viral Culture Tests
- Direct Fluorescent Antibody Test
- Serological Tests

Type of Flu Insights:

Type A Flu
Type B Flu
Type C Flu

End User Insights:

Hospitals
Diagnostic Laboratories
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan influenza diagnostics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan influenza diagnostics market?
What is the breakup of the Japan influenza diagnostics market on the basis of product?
What is the breakup of the Japan influenza diagnostics market on the basis of test type?
What is the breakup of the Japan influenza diagnostics market on the basis of type of flu?
What is the breakup of the Japan influenza diagnostics market on the basis of end user?
What are the various stages in the value chain of the Japan influenza diagnostics market?
What are the key driving factors and challenges in the Japan influenza diagnostics?
What is the structure of the Japan influenza diagnostics market and who are the key players?
What is the degree of competition in the Japan influenza diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Influenza Diagnostics Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Influenza Diagnostics Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Influenza Diagnostics Market - Breakup by Product

6.1 Test Kit and Reagents
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Instruments
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Others
- 6.3.1 Historical and Current Market Trends (2019-2024)
- 6.3.2 Market Forecast (2025-2033)

7 Japan Influenza Diagnostics Market - Breakup by Test Type

7.1 Molecular Diagnostic Tests
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Segmentation
  - 7.1.3.1 Polymerase Chain Reaction
  - 7.1.3.2 Isothermal Nucleic Acid Amplification Tests
  - 7.1.3.3 Others
- 7.1.4 Market Forecast (2025-2033)
7.2 Traditional Diagnostic Tests
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Segmentation
  - 7.2.3.1 Rapid Influenza Diagnostic Tests
  - 7.2.3.2 Viral Culture Tests
  - 7.2.3.3 Direct Fluorescent Antibody Test
  - 7.2.3.4 Serological Tests
- 7.2.4 Market Forecast (2025-2033)

8 Japan Influenza Diagnostics Market - Breakup by Type of Flu

8.1 Type A Flu
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Type B Flu
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Type C Flu
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)

9 Japan Influenza Diagnostics Market - Breakup by End User

9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Diagnostic Laboratories
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Others
- 9.3.1 Historical and Current Market Trends (2019-2024)
- 9.3.2 Market Forecast (2025-2033)

10 Japan Influenza Diagnostics Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Influenza Diagnostics Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis